Literature DB >> 24094598

A tale of two diseases: the history of inflammatory bowel disease.

Daniel J Mulder1, Angela J Noble2, Christopher J Justinich2, Jacalyn M Duffin3.   

Abstract

'Inflammatory bowel disease' (IBD) sounds like a straightforward term - a disease of inflammation in the bowel. However, the history of IBD reveals a story of a nefariously complex set of idiopathic conditions. IBD defies definition, in part because its pathophysiology is not completely understood. For the same reason and despite substantial advances in research, IBD also defies cure. At best, IBD can be defined as a disease of disruption - disrupted physiology, microbiology, immunology and genetics. The term 'IBD' is most often used to describe two separate conditions: ulcerative colitis (UC) and Crohn's disease (CD). This paper reviews the history of IBD, considering the ever-evolving understanding of both UC and CD. Beyond its intrinsic interest, the history of IBD exemplifies a pattern that is becoming increasingly familiar in the 21st century - the story of a chronic, incurable disease that defies the best efforts to treat it.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Crohn's disease;; History;; Inflammatory bowel disease;; Ulcerative colitis

Mesh:

Year:  2013        PMID: 24094598     DOI: 10.1016/j.crohns.2013.09.009

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  44 in total

Review 1.  The global burden of IBD: from 2015 to 2025.

Authors:  Gilaad G Kaplan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-01       Impact factor: 46.802

2.  Are we addressing the top 10 research priorities in IBD?

Authors:  Jeroen Geldof; Jean-Frédéric LeBlanc; Laura Lucaciu; Jonathan Segal; Charlie W Lees; Ailsa Hart
Journal:  Frontline Gastroenterol       Date:  2020-11-11

Review 3.  Where Do We Stand in the Behavioral Pathogenesis of Inflammatory Bowel Disease? The Western Dietary Pattern and Microbiota-A Narrative Review.

Authors:  Iwona Krela-Kaźmierczak; Oliwia Zakerska-Banaszak; Marzena Skrzypczak-Zielińska; Liliana Łykowska-Szuber; Aleksandra Szymczak-Tomczak; Agnieszka Zawada; Anna Maria Rychter; Alicja Ewa Ratajczak; Kinga Skoracka; Dorota Skrzypczak; Emilia Marcinkowska; Ryszard Słomski; Agnieszka Dobrowolska
Journal:  Nutrients       Date:  2022-06-17       Impact factor: 6.706

Review 4.  NLRP3 inflammasome in colitis and colitis-associated colorectal cancer.

Authors:  Agampodi Promoda Perera; Karishma Sajnani; Joanne Dickinson; Rajaraman Eri; Heinrich Körner
Journal:  Mamm Genome       Date:  2018-09-11       Impact factor: 2.957

5.  Temporal induction of intestinal epithelial hypoxia-inducible factor-2α is sufficient to drive colitis.

Authors:  Sumeet Solanki; Samantha N Devenport; Sadeesh K Ramakrishnan; Yatrik M Shah
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-06-26       Impact factor: 4.052

6.  Increased Prevalence of Esophageal Eosinophilia in Patients with Inflammatory Bowel Disease.

Authors:  Y Claire Fan; David Steele; Bharati Kochar; Diana Arsene; Millie D Long; Evan S Dellon
Journal:  Inflamm Intest Dis       Date:  2019-03-20

Review 7.  Targeting ectonucleotidases to treat inflammation and halt cancer development in the gut.

Authors:  Maria Serena Longhi; Lili Feng; Simon C Robson
Journal:  Biochem Pharmacol       Date:  2021-01-15       Impact factor: 5.858

Review 8.  Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis.

Authors:  Jie Cai; Lulu Sun; Frank J Gonzalez
Journal:  Cell Host Microbe       Date:  2022-03-09       Impact factor: 21.023

Review 9.  Should We Divide Crohn's Disease Into Ileum-Dominant and Isolated Colonic Diseases?

Authors:  Parambir S Dulai; Siddharth Singh; Niels Vande Casteele; Brigid S Boland; Jesus Rivera-Nieves; Peter B Ernst; Lars Eckmann; Kim E Barrett; John T Chang; William J Sandborn
Journal:  Clin Gastroenterol Hepatol       Date:  2019-04-19       Impact factor: 13.576

Review 10.  Glucocorticoid Therapy in Inflammatory Bowel Disease: Mechanisms and Clinical Practice.

Authors:  Stefano Bruscoli; Marta Febo; Carlo Riccardi; Graziella Migliorati
Journal:  Front Immunol       Date:  2021-06-03       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.